Cylembio is a therapeutic cancer vaccine candidate that targets cells and immune-suppressive cells in the tumor microenvironment through activation and expansion of T cells against IDO1 and/or PD-L1 ...

Approved in 2022, Skysona is indicated to slow the progression of neurologic dysfunction in boys 4 to 17 years of age with early, active cerebral adrenoleukodystrophy.

Ianalumab added to eltrombopag significantly prolonged the time to treatment failure (TTF) in adults with primary immune thrombocytopenia (ITP), a B cell-driven autoimmune disease, according to phase ...

The KEYNOTE-905 study is ongoing and will evaluate other endpoints including EFS, OS, and pCR rate for neoadjuvant and adjuvant pembrolizumab vs surgery alone.

HealthDay News — Few patients with myelodysplastic syndromes (MDS) receive treatment with hypomethylating agents (HMAs), with evidence of age-, sex-, and race-related disparities, according to a study ...

On July 29, he was removed from his role after some conservative figures such as far-right activist and conspiracy theorist Laura Loomer criticized his approach to drug approvals and his past ...

Discordance was greater for middle-aged adults, racial and ethnic minorities, and for those with lower educational attainment.

Forty-six point four percent said they would accept one or more missing vaccines if they could be provided during their ED visit.

Iron sucrose injection is an iron replacement product indicated for the treatment of iron deficiency anemia in patients with chronic kidney disease.

HealthDay News — Electronic cigarette (e-cigarette) flavor restriction policies are associated with reductions in e-cigarette use, according to a study published online July 30 in JAMA Network Open.

Genio is a bilateral hypoglossal nerve stimulation system that consists of an implantable stimulator and a sleep wearable.

Sustained benefits seen in overall survival, progression-free survival, objective response rate with combo vs sunitinib.